Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gad Getz

Showing results (71-80 of 396) with videos related to

Pageof 40
Sort By:
NPJ Precision Oncology|September 27, 2025
Single-cell RNA-sequencing of BCG naïve and recurrent non-muscle invasive bladder cancer reveals a CD6/ALCAM-mediated immune-suppressive pathwayIvan Juric, Emily E Fink, Hong Qiu, et al.
Cell Systems|March 30, 2018
Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic PipelinesKyle Ellrott, Matthew H Bailey, Gordon Saksena, et al.
Nature Genetics|November 22, 2016
Tumor-suppressor genes that escape from X-inactivation contribute to cancer sex biasAndrew Dunford, David M Weinstock, Virginia Savova, et al.
Plos One|February 6, 2014
A pan-cancer analysis of transcriptome changes associated with somatic mutations in U2AF1 reveals commonly altered splicing eventsAngela N Brooks, Peter S Choi, Luc de Waal, et al.
Genome Research|July 18, 2012
Paired-end sequencing of Fosmid libraries by IlluminaLouise J S Williams, Diana G Tabbaa, Na Li, et al.
Leukemia|July 28, 2025
Rare germline variant in NFATC4 associated with familial CLLGilad Itchaki, Harrison Bai, Grace Tiao, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 23, 2004
Design principle of gene expression used by human stem cells: implication for pluripotencyMichal Golan-Mashiach, Jean-Eudes Dazard, Sharon Gerecht-Nir, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 10, 2016
Survival of Del17p CLL Depends on Genomic Complexity and Somatic MutationLijian Yu, Haesook T Kim, Siddha Kasar, et al.
Cancer Cell|June 15, 2007
Identification of the JNK signaling pathway as a functional target of the tumor suppressor PTENIgor Vivanco, Nicolaos Palaskas, Chris Tran, et al.
Nature|November 8, 2005
BRAF mutation predicts sensitivity to MEK inhibitionDavid B Solit, Levi A Garraway, Christine A Pratilas, et al.
Pageof 40

Showing results (71-80 of 396) with videos related to

Sort By:
Pageof 40
NPJ Precision Oncology|September 27, 2025
Single-cell RNA-sequencing of BCG naïve and recurrent non-muscle invasive bladder cancer reveals a CD6/ALCAM-mediated immune-suppressive pathwayIvan Juric, Emily E Fink, Hong Qiu, et al.
Cell Systems|March 30, 2018
Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic PipelinesKyle Ellrott, Matthew H Bailey, Gordon Saksena, et al.
Nature Genetics|November 22, 2016
Tumor-suppressor genes that escape from X-inactivation contribute to cancer sex biasAndrew Dunford, David M Weinstock, Virginia Savova, et al.
Plos One|February 6, 2014
A pan-cancer analysis of transcriptome changes associated with somatic mutations in U2AF1 reveals commonly altered splicing eventsAngela N Brooks, Peter S Choi, Luc de Waal, et al.
Genome Research|July 18, 2012
Paired-end sequencing of Fosmid libraries by IlluminaLouise J S Williams, Diana G Tabbaa, Na Li, et al.
Leukemia|July 28, 2025
Rare germline variant in NFATC4 associated with familial CLLGilad Itchaki, Harrison Bai, Grace Tiao, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 23, 2004
Design principle of gene expression used by human stem cells: implication for pluripotencyMichal Golan-Mashiach, Jean-Eudes Dazard, Sharon Gerecht-Nir, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 10, 2016
Survival of Del17p CLL Depends on Genomic Complexity and Somatic MutationLijian Yu, Haesook T Kim, Siddha Kasar, et al.
Cancer Cell|June 15, 2007
Identification of the JNK signaling pathway as a functional target of the tumor suppressor PTENIgor Vivanco, Nicolaos Palaskas, Chris Tran, et al.
Nature|November 8, 2005
BRAF mutation predicts sensitivity to MEK inhibitionDavid B Solit, Levi A Garraway, Christine A Pratilas, et al.
Pageof 40